Robert F. Martinovich - 21 May 2025 Form 3 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Role
Director
Signature
/s/ Mark D. Tattoli, Attorney-in-Fact
Issuer symbol
CLB
Transactions as of
21 May 2025
Net transactions value
$0
Form type
3
Filing time
30 May 2025, 16:15:08 UTC
Previous filing
25 Feb 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MARTINOVICH ROBERT F Director 6316 WINDFERN RD, HOUSTON /s/ Mark D. Tattoli, Attorney-in-Fact 30 May 2025 0001251674

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLB Common Stock 0 21 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CLB Restricted Shares 21 May 2025 Common Stock 8,069 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares were granted to Mr. Martinovich upon his election to the Board of Directors of Core Laboratories Inc. on May 21, 2025, consistent with the annual grant given to the Company's other non-executive directors made on April 1, 2025. The Restricted Shares will vest, without performance criteria, on April 1, 2026, subject to the terms of issuance.